People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| H-Cyte, Inc. | — | Other Health Care | Series A | $14.6M | $58.1M | 2016 |
| Biomimetic Therapeutics, Inc. | — | Biotechnology | Series A | $10.9M | $105.5M | 2009 |
| ExtraOrtho, Inc. | — | Other Health Care | Seed | $3.6M | $89.7M | 2010 |
Larry Papasan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Larry Papasan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gorlin | 1 | 11 |
| Chris Ehrlich | 1 | 6 |
| James Murphy | 1 | 5 |
| John C. Thomas, Jr. | 1 | 5 |
| William E. Horne | 1 | 4 |
| Charles Farrahar | 1 | 4 |
| Ken Woody | 1 | 4 |
| Brian Austin | 1 | 4 |
| John Blank | 1 | 2 |
| Charles Federico | 1 | 2 |
| John Thomas, Jr. | 1 | 2 |
| SAMUEL LYNCH | 1 | 2 |
| Jeffrey Wright | 1 | 2 |
| Steven Hirsch | 1 | 2 |
| Douglas Watson | 1 | 2 |
| James Andrews | 1 | 2 |
| Randal R. Betz | 1 | 2 |
| Scott Haufe | 1 | 1 |
| Patrick Kullman | 1 | 1 |
| C.A. Hennies | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.